X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Sensex Ends 732 Points Higher; Realty and Metal Stocks Gain the Most
Fri, 12 Oct Closing | Monish Vora, TM Team

Indian share markets continued their momentum seen during the day and ended their session on a positive note today. Gains were largely seen in the stocks from the realty sector and metal sector.

At the closing bell, the BSE Sensex stood higher by 732 points (up 2.2%) and the NSE Nifty closed higher by 237 points (up 2.3%). The BSE Mid Cap index ended the day up by 2.4%, while the BSE Small Cap index ended the day up by 2.6%.

Asian stock markets finished on a positive note as of the most recent closing prices. The Hang Seng was up 2.1% and the Nikkei was trading up by 0.5%. The Shanghai Composite stood higher by 0.9%.

The rupee was trading at 73.66 to the US$ at the time of writing.

In the news from the banking space, as per a leading financial daily, the recent correction in stock markets has given a blow to the government as the value of government holdings in listed PSUs has reduced by Rs 6 trillion from their one-year highs.

Also, it's interesting to compare how these stocks performed compared to the frontline index - BSE Sensex.

The BSE-PSU index, which includes many companies from the PSU space, considerably underperformed the BSE Sensex.

Underperformance of BSE PSU Index

For three out of five years, the BSE-PSU index considerably underperformed the BSE Sensex. From 2014 till date, the BSE-PSU index gave a meagre annualised return of 3%. Whereas, the BSE Sensex delivered 14%.

This underperformance can be attributed to sector specific events such as non-performing assets (NPAs) in the banking space and rising oil prices that impacted OMCs, among others.

--- Advertisement ---
The No. 1 Book on Investing That May Never Be Printed Again…

Equitymaster's Secrets :: Our Biggest Lessons From Over Two Decades Of Investing Journey
Equitymaster's Secrets is the No. 1 book on investing you'll find anywhere – if you ask us.

Not only does it contain investing wisdom and secrets no one else will ever tell you…

…it also reveals the exact strategies behind our most successful stock picks!

This is a book no serious investor can do without!

If you want a copy for yourself, just let us know, and we'll have a hardbound copy sent over wherever you like (as long as it is within India) – virtually for free.

Click here for details.

We have very few copies of this book left, however – and we have no plans of printing any more. Please claim your copy ASAP if you don't want to miss out.
------------------------------

In the news from pharma space, as per a leading financial daily, drug firm Zydus Cadila said it has received tentative approval from the US health regulator to market Linagliptin and Metformin Hydrochloride tablets, used to control of blood sugar levels in diabetic patients.

The company said the drug will be produced at the group's formulations manufacturing facility at special economic zone (SEZ), Ahmedabad.

The group has more than 221 approvals, and so far has filed over 330 abbreviated new drug applications (ANDAs) since it started filings in 2003-04.

Speaking of drug approvals, note that Indian pharma companies catering to the US markets are breathing a sigh of relief. After being adversely affected by import bans and the suspension of new drug approvals from manufacturing facilities in the past three years, there has been a sharp pick-up in new drug approvals in FY17.

Even the total filings of abbreviated new drug applications (ANDAs) for generic drugs rose to 1,292 in FY17 from 852 in the previous year. Faster approvals expedite the commercialisation of product pipelines of domestic pharma companies spurring growth. At the same time, however, it has raised the intensity of competition resulting in pricing pressures. The price erosion has been further compounded by a consolidation among US distributors and the decline in the number of products going off-patent over the past few years.

In other words, acceleration in generic drug approvals is like a double-edged sword. The growth boost can be quickly offset by the ensuing pricing pressures. Pharma companies that invest in creating a pipeline of complex generics or building competencies in alternative dosage forms are better equipped to tackle the changing dynamics in the US generics market.

Moving on, stocks from the power sector were in focus today on news that the Supreme Court agreed to hear plea on tariff hike after two weeks and will examine them for Adani Power and Tata Power.

As per the news, hopes are that the Gujarat government's panel may bring Rs 1.29 trillion relief to state's three stranded power projects.

Following the above news, shares of Tata Power and Adani Power witnessed buying interest and soared as much as 16% in today's trade.

In the news from the commodity space, gold continued its uptrend and witnessed buying interest for the third day today. Gains were seen on the back of increased buying by jewelers to meet the festive demand and positive cues from the global financial markets.

Also, the weakness in the US dollar also meant gold prices trade on a positive note.

To know what's moving the Indian stock markets today, check out the most recent share market updates here.

You can listen to this week's stock market updates in our brand new podcast below. Tune in!

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Equitymaster requests your view! Post a comment on "Sensex Ends 732 Points Higher; Realty and Metal Stocks Gain the Most". Click here!

  

Stock Market Updates

Most Active Small-Cap Stocks Today; JET AIRWAYS the Most Traded (Today's Market)

Mar 26, 2019 04:50 PM

Here's a list of most active small-cap stocks today. It also includes information on BSE Smallcap index and the broader benchmark indices.

Top 5 Mid-Cap Gainers Today; GMR INFRA Leads the Pack (Today's Market)

Mar 26, 2019 04:50 PM

Here's a list of 5 stocks that gained the most in the BSE Mid-Cap Index today. It also includes information on BSE Mid-Cap index and the broader benchmark indices.

TAKE SOLUTIONS Surges by 10%; BSE IT Index Down 0.7% (Today's Market)

Mar 26, 2019 03:24 PM

TAKE SOLUTIONS share price has surged by 10% and its current market price is Rs 137. The BSE IT is down by 0.7%. The top gainers in the BSE IT Index is TAKE SOLUTIONS (up 10.0%). The top losers are TCS (down 0.4%) and CYIENT (down 0.6%).

JUBILANT LIFE SCIENCES Plunges by 5%; BSE 500 Index Up 1.0% (Today's Market)

Mar 26, 2019 03:24 PM

JUBILANT LIFE SCIENCES share price has plunged by 5% and its current market price is Rs 726. The BSE 500 is up by 1.0%. The top gainers in the BSE 500 Index are GMR INFRA (up 14.0%) and HCC (up 9.8%). The top losers are JUBILANT LIFE SCIENCES (down 5.2%) and NLC INDIA LTD (down 9.2%).

LAURUS LABS LTD Surges by 6%; BSE HEALTHCARE Index Up 0.4% (Today's Market)

Mar 26, 2019 03:04 PM

LAURUS LABS LTD share price has surged by 6% and its current market price is Rs 397. The BSE HEALTHCARE is up by 0.4%. The top gainers in the BSE HEALTHCARE Index is LAURUS LABS LTD (up 5.7%). The top losers are GSK PHARMA (down 0.2%) and SUN PHARMA ADV. RES. (down 0.3%).

Sensex Trades Flat; IT Stocks Under Pressure (Today's Market)

Mar 26, 2019 12:30 pm

The BSE Sensex is trading up by 33 points, while the NSE Nifty is trading up by 12 points.

View More Indian Share Market News

Most Popular

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

This Small Cap Stock Could Offer Triple Digit Gains from its Current Price(Profit Hunter)

Mar 19, 2019

If you are still waiting for signals, remember, there is no correct timing, only right time to Buy stocks. For select small caps, that time is now.

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Mar 26, 2019 03:35 PM

MARKET STATS